Finance

Lists
353810:KOSDAQ
Easy Bio Inc
â‚©5,680.00
+0.18%
(+10.00) 1D
Oct 19, 3:30:29 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 353810...
Open
â‚©5,600
High
â‚©5,680
Low
â‚©5,530
Mkt. cap
187.91B
Avg. vol.
81.11K
Volume
27.97K
Dividend
4.40%
Quarterly dividend
â‚©63
Ex-dividend date
Mar 9, 2026
P/E ratio
4.72
52-wk high
â‚©8,560
52-wk low
â‚©5,400
EPS
â‚©1,204
Shares outstanding
33.08M
No. of employees
140
Open
â‚©5,600
High
â‚©5,680
Low
â‚©5,530
Mkt. cap
187.91B
Avg. vol.
81.11K
Volume
27.97K
Dividend
4.40%
Quarterly dividend
â‚©63
Ex-dividend date
Mar 9, 2026
P/E ratio
4.72
52-wk high
â‚©8,560
52-wk low
â‚©5,400
EPS
â‚©1,204
Shares outstanding
33.08M
No. of employees
140
News stories
From web sources and news partners
About Easy Bio Inc
CEO-
Employees140
Founded2011
Headquarters-
SectorFood
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
116.90B
129.32B
130.69B
148.13B
Cost of goods sold
86.92B
93.65B
95.95B
110.25B
Cost of revenue
86.92B
93.65B
95.95B
110.25B
Research and development expenses
749.16M
916.09M
996.55M
703.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.70B
19.25B
18.62B
19.93B
Operating expense
18.73B
22.07B
21.53B
22.82B
Total operating expenses
105.65B
115.73B
117.47B
133.07B
Operating income
11.25B
13.59B
13.22B
15.06B
Other non operating income
-212.73M
-194.45M
-275.62M
-191.82M
EBT including unusual items
11.65B
13.76B
15.65B
15.37B
EBT excluding unusual items
11.49B
13.43B
15.29B
15.25B
Income tax expense
3.02B
3.00B
3.98B
4.52B
Effective tax rate
25.88%
21.77%
25.44%
29.37%
Other operating expenses
556.51M
554.85M
981.47M
585.39M
Net income
8.31B
10.13B
11.19B
10.19B
Net profit margin
7.11%
7.83%
8.56%
6.88%
Earnings per share
-
-
-
-
Interest and investment income
491.14M
544.93M
526.32M
474.28M
Interest expense
-1.51B
-1.61B
-1.55B
-1.52B
Net interest expenses
-1.02B
-1.06B
-1.03B
-1.04B
Depreciation and amortization charges
277.74M
303.42M
302.80M
400.02M
EBITDA
13.28B
15.72B
15.34B
17.57B
Gain or loss from assets sale
-481.00K
-3.63M
63.74M
-20.00M
AI content may include mistakes. Learn more
Google apps